Cargando…

Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach

Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy...

Descripción completa

Detalles Bibliográficos
Autores principales: Buré, Lionel, Boucher, Louis-Martin, Blumenkrantz, Miriam, Schob, Stefan, Lafaye de Micheaux, Pierre, Reinhold, Caroline, Gallix, Benoit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549694/
https://www.ncbi.nlm.nih.gov/pubmed/28792506
http://dx.doi.org/10.1371/journal.pone.0182169
_version_ 1783256012717817856
author Buré, Lionel
Boucher, Louis-Martin
Blumenkrantz, Miriam
Schob, Stefan
Lafaye de Micheaux, Pierre
Reinhold, Caroline
Gallix, Benoit
author_facet Buré, Lionel
Boucher, Louis-Martin
Blumenkrantz, Miriam
Schob, Stefan
Lafaye de Micheaux, Pierre
Reinhold, Caroline
Gallix, Benoit
author_sort Buré, Lionel
collection PubMed
description Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size.
format Online
Article
Text
id pubmed-5549694
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55496942017-08-12 Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach Buré, Lionel Boucher, Louis-Martin Blumenkrantz, Miriam Schob, Stefan Lafaye de Micheaux, Pierre Reinhold, Caroline Gallix, Benoit PLoS One Research Article Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size. Public Library of Science 2017-08-08 /pmc/articles/PMC5549694/ /pubmed/28792506 http://dx.doi.org/10.1371/journal.pone.0182169 Text en © 2017 Buré et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Buré, Lionel
Boucher, Louis-Martin
Blumenkrantz, Miriam
Schob, Stefan
Lafaye de Micheaux, Pierre
Reinhold, Caroline
Gallix, Benoit
Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title_full Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title_fullStr Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title_full_unstemmed Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title_short Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach
title_sort can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? an in-vitro approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549694/
https://www.ncbi.nlm.nih.gov/pubmed/28792506
http://dx.doi.org/10.1371/journal.pone.0182169
work_keys_str_mv AT burelionel canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT boucherlouismartin canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT blumenkrantzmiriam canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT schobstefan canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT lafayedemicheauxpierre canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT reinholdcaroline canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach
AT gallixbenoit canmagneticresonancespectroscopydifferentiatemalignantandbenigncausesoflymphadenopathyaninvitroapproach